In this issue of Heart Failure Clinics, guest editor Dr. Kevin S. Shah brings his considerable expertise to the topic of Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options. Patient selection and timely referral are critical factors in managing advanced heart disease and ensuring patients receive optimal therapy. This issue addresses strategic assessment of patient health status, comorbidities, and disease progression, in order to make informed decisions about when and how to implement advanced heart disease therapies—potentially extending life expectancy and enhancing quality of life for high-risk patients.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction - p. 119 9. Hypertrophic Cardiomyopathy: Patient Selection, Referral Timing, and Advanced Therapy Options - p. 133 10. Approach to Ventricular Arrhythmias in Heart Failure - p. 149 11. Patient Selection, Referral Framework and Emerging Therapies in Severe Ischemic Heart Failure: A State-of-the-Art Review - p. 163 12. Sex-Based Differences in Advanced Heart Failure - p. 183 13. Optimizing Patient Selection, Referral Timing, and Advanced Therapies in Cardiogenic Shock - p. 193 14. Approach to Mitral Regurgitation in Advanced Heart Failure - p. 209 15. Multimodality Imaging in Hypertrophic Cardiomyopathy - p. 221 16. Unique Challenges of Adult Congenital Heart Disease in CardioOncology - p. 237 17. Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances - p. 243
In this issue of Heart Failure Clinics, guest editor Dr. Kevin S. Shah brings his considerable expertise to the topic of Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options. Patient selection and timely referral are critical factors in managing advanced heart disease and ensuring patients receive optimal therapy. This issue addresses strategic assessment of patient health status, comorbidities, and disease progression, in order to make informed decisions about when and how to implement advanced heart disease therapies—potentially extending life expectancy and enhancing quality of life for high-risk patients.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction - p. 119 9. Hypertrophic Cardiomyopathy: Patient Selection, Referral Timing, and Advanced Therapy Options - p. 133 10. Approach to Ventricular Arrhythmias in Heart Failure - p. 149 11. Patient Selection, Referral Framework and Emerging Therapies in Severe Ischemic Heart Failure: A State-of-the-Art Review - p. 163 12. Sex-Based Differences in Advanced Heart Failure - p. 183 13. Optimizing Patient Selection, Referral Timing, and Advanced Therapies in Cardiogenic Shock - p. 193 14. Approach to Mitral Regurgitation in Advanced Heart Failure - p. 209 15. Multimodality Imaging in Hypertrophic Cardiomyopathy - p. 221 16. Unique Challenges of Adult Congenital Heart Disease in CardioOncology - p. 237 17. Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances - p. 243
